Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial
Authors
- Ahmad Shamabadi (ORCID: https://orcid.org/0000-0002-5211-2827)
- Mohammad Reza Khodaie Ardakani (ORCID: https://orcid.org/0000-0002-5057-3494)
- Bita Fallahpour
- Kimia Farahmand
- Kimia Kazemzadeh (ORCID: https://orcid.org/0000-0002-6948-4838)
- Shahin Akhondzadeh (ORCID: https://orcid.org/0000-0002-2277-5101)
- Elham-Sadat Rafiei-Tabatabaei
Institutions
- Roozbeh Hospital (IR)
- Razi Hospital (IR)
- University of Social Welfare and Rehabilitation Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- The International Journal of Neuropsychopharmacology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1093/ijnp/pyae051
- Citations
- 3
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16